Volume 96 Issue 3 | p. 13 | Concentrates
Issue Date: January 15, 2018

Wacker to make active for Chiesi drug

Department: Business
Keywords: Biologics, reteplase, Wacker, heart drug
[+]Enlarge
FDA recently inspected this Wacker plant in Halle, Germany.
Credit: Wacker Chemie
A photo of Wacker's biologic drug plant in Halle, Germany.
 
FDA recently inspected this Wacker plant in Halle, Germany.
Credit: Wacker Chemie

Wacker Biotech will produce reteplase, the active ingredient in Retavase, for the Italian drug company Chiesi, which is relaunching the drug in the U.S. Reteplase is a recombinant nonglycosylated form of human tissue plasminogen activator used to dissolve blood clots. Wacker will produce the drug at its plant in Halle, Germany, which was recently inspected by the U.S. Food & Drug Administration. Roche previously made the active for Chiesi.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment